Health Care

FDA approves a new OxyContin

LOS ANGELES-The U.S. Food and Drug Administration approved a new form of the powerful and controversial pain reliever OxyContin that is designed to be more resistant to abuse, but experts warned the drug could wind up having the opposite effect.

Health Care

To comply with Obamacare, insurers write rebate checks

An Affordable Care Act rule that requires health insurers to spend at least 80 percent of premiums on health care, rather than administration or profits, resulted in $332 million in rebates nationally, including $3.57 million owed by Blue Cross and Blue Shield of Kansas City.